XCF Global and OpenSponsorship partner to provide sports, entertainment, and music industries with carbon-neutral air travel opportunities
Initiative drives awareness around reducing aviation emissions by offering a practical carbon offset solution
Partnership empowers athletes, entertainers, and musicians to leverage their platforms to promote positive societal change
Builds on the targeted immune activation model validated by mipletamig in AML, adapted for prostate cancer.
Engineered for precision T-cell activation in prostate cancer; part of Aptevo's growing CRIS-7-derived CD3 portfolio targeting both hematologic and solid tumors
Read More
Q2 2025 Results and Subsequent Events
Total net assets of $23.2 million and working capital of $22.8 million as at Q2 2025, including an additional $3.6 million in non-dilutive government funding received in Q2 2025 from existing programs.
Company sets stage for potential U.S. growth with ALTA and being most OBBB ready solution
IEA names Nano One a top LFP innovator, meeting demand of global push to localize
Nano One begins trading on the U.S. OTCQB under the ticker "NNOMF"
Results from the AGM held on May 23, 2025 were announced with all matters presented for shareholder approval being approved.
Largest ARR Renewal with Fortune 50 client and expansion of agentic AI based products and solutions
Agentic AI partnership with Google leading to disruptive product offerings
Read More
Highlights for the Quarter ended June 30, 2025:
Management and advisory fee revenue of $18.8 million for the quarter ended June 30, 2025, a 66% increase from the second quarter of 2024
Net loss attributable to Horizon Kinetics Holding Corporation of $(10.5) million, or $(0.56) per common share for the three months ended June 30, 2025
Operating income for the second quarter of 2025 was $2.5 million, an increase of $3.2 million from a $0.6 million loss during the second quarter of 2024
Assets under management ("AUM") of $10.5 billion as of June 30, 2025, an increase of 7% from December 31, 2024 and 43% from June 30, 2024
Board of Directors declares a $0.071 per share dividend
Q2 Total Revenue: $5.7 million; Six Months Total Revenue: $11.2 million
Cash Flow from Operations for 1H 2025: $0.9 million
Cash and Equivalents: $8.3 million, including Restricted Cash of $1.0 million
No Long-Term Debt
Investor Conference Call TODAY at 4:30 p.m. Eastern Time
Read MoreTotal financing for prospective team acquisition now approaching $2 billion, in addition to more than $1 billion for team's portion of stadium financing.
Dreamers' leadership also announces continued progress on downtown office signage and renovation initiatives.
Read More